The human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: Identification of seven non-coding exons and characterization of a novel promoter

Biochemical Journal

Volumn 367, Issue 3, 2002, Pages 629-640

  Whetstine, Johnathan R ^a   Flatley, Robin M ^a   Matherly, Larry H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alternative splicing; Methotrexate; Tissue specificity; Transcription

Indexed keywords

DNA; GENES; PATHOLOGY; PROTEINS; RNA; TISSUE;

TRANSCRIPTION;

BIOCHEMISTRY;

COMPLEMENTARY DNA; GENE PRODUCT; LEUCINE ZIPPER PROTEIN; MESSENGER RNA; REDUCED FOLATE CARRIER; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3;

ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXON; FOLIC ACID DEFICIENCY; GENE AMPLIFICATION; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE MAPPING; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PLACENTA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FAMILY; RNA TRANSLATION; SKELETAL MUSCLE; SPLICEOSOME; TISSUE SPECIFICITY; UNTRANSLATED REGION;

5' UNTRANSLATED REGIONS; BASE SEQUENCE; BLOTTING, NORTHERN; CARRIER PROTEINS; DNA; EXONS; HUMANS; MEMBRANE TRANSPORT PROTEINS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0036846897     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20020512     Document Type: Article

References (57)

1. Stokstad, E. L. R. (1990) Historical perspective on key advances in the biochemistry and physiology of folates. In Folic Acid Metabolism in Health and Disease (Picciano, M. F., Stokstad, E. L. R. and Gregory, J. F., eds.), pp. 1-21, Wiley-Liss, New York
2. Refsum, H., Ueland, P., Nygard, O. and Vollset, S. E. (1998) Homocysteine and cardiovascular disease. Annu. Rev. Med. 49, 31-62
3. Butterworth, Jr, C. E. and Bendich, A. (1996) Folic acid and the prevention of birth defects. Annu. Rev. Nutr. 16, 73-97
4. Hernandez-Diaz, S., Werler, M. M., Walker, A. M. and Mitchell, A. A. (2000) Folic acid antagonists during pregnancy and the risk of birth defects. N. Engl. J. Med. 343, 1608-1614
5. MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: Results of the medical research council vitamin study. Lancet 321, 131-137
6. Berry, R. J., Li, Z., Erickson, J. D., Li, S., Moore, C. A., Wang, H., Mulinare, J., Zhao, P., Wong, L.-Y., Gindler, J. et al. (1999) Prevention of neural-tube defects with folic acid in China. N. Engl. J. Med. 341, 1485-1490
7. Honein, M. A., Paulozzi, L. J., Mathews, T. J., Erickson, J. D. and Wong, L.-Y. (2001) Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA, J. Am. Med. Assoc. 285, 2981-2986
8. Serot, J. M., Christmann, D., Dubest, T., Bene, M. C. and Faure, G. C. (2001) CSF-folate levels are decreased in late-onset AD patients. J. Neural Transm. 108, 93-99
9. Albanes, D. and Glynn, S. A. (1994) Folate and cancer: A review of the literature. Nutr. Cancer 22, 101-119
10. Kim, Y. I.J. (1999) Folate and carcinogenesis: Evidence, mechanisms and implications. J. Nutr. Biochem. 10, 66-88
11. Choi, S.-W. and Mason, J. B. (2000) Folate and carcinogenesis: An integrated scheme. J. Nutr. 130, 129-132
12. Sirotnak, F. M. and Tolner, B. (1999) Carrier mediated membrane transport of folates in mammalian cells. Annu. Rev. Nutr. 19, 91-122
13. Matherly, L. H. (2001) Molecular and cellular biology of the human reduced folate carrier. Prog. Nucleic Acid Res. Mol. Biol. 67, 131-162
14. Goldman, I. D. and Matherly, L. H. (1985) The cellular pharmacology of methotrexate. Pharmacol. Ther. 28, 77-100
15. Jansen, G. (1999) Receptor- and carrier-mediated transport systems for folates and antifolates. Exploitation for folate chemotherapy and immunotherapy. In Anticancer Development Guide: Antifolate Drugs in Cancer Therapy (Jackman, A. L., ed.), pp. 293-321, Humana Press, Totowa, NJ
16. Sirotnak, F. M. (1985) Obligate genetic expression in tumor cells of a fetal membrane property mediating 'folate' transport: Biological significance and implications for improved therapy of human cancer. Cancer Res. 45, 3992-4000
17. Matherly, L. H. and Taub, J. W. (1996) Methotrexate pharmacology and resistance in childhood acute lymphoblastic leukemia. Leuk. Lymphoma 21, 359-368
18. Guo, W., Healey, J. H., Meyeers, P. A., Ladanyai, M., Huvos, A. G., Bertino, J. R. and Gorlick, R. (1999) Mechanisms of methotrexate resistance in osteosarcoma. Clin. Cancer Res. 5, 621-627
19. Schuetz, J. D., Matherly, L. H., Westin, E. H. and Goldman, I. D. (1988) Evidence for a functional defect in the translocation of the methotrexate transport carrier in a methotrexate resistant murine L1210 leukemia cell line. J. Biol. Chem. 263, 9840-9847
20. Wong, S. C., McQuade, R., Proefke, S. A. and Matherly, L. H. (1997) Human K562 transfectants expressing high levels of reduced folate carrier but exhibiting low transport activity. Biochem. Pharmacol. 53, 199-206
21. Jansen, G., Mauritz, R., Drori, S., Sprecher, H., Kathman, I., Bunni, M., Priest, D. G., Noordhuis, P., Schornagel, J. H., Pinedo, H. M. et al. (1998) A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance. J. Biol. Chem. 273, 30189-30198
22. Gong, M., Yess, J., Connolly, T., Ivy, S. P., Ohnuma, T., Cowanm, K. H. and Moscow, J. A. (1997) Molecular mechanism of antifolate transport deficiency in a methotrexate resistant MOLT-3 human leukemia cell line. Blood 89, 2494-2499
23. Sadlish, H., Murray, R. C., Williams, F. M. R. and Flintoff, W. F. (2000) Mutations in the reduced folate carrier affect protein localization and stability. Biochem. J. 346, 509-516
24. Sirotnak, F. M., Moccio, D. M., Kelleher, L. E. and Goutas, L. J. (1981) Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate resistant L1210 clonal cell lines derived in vivo. Cancer Res. 41, 4442-4452
25. Zhang, L., Taub, J. W., Williamson, M., Wong, S. C., Hukku, B., Pullen, J., Ravindranath, Y. and Matherly, L. H. (1998) Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: Relationship to immunophenotype and ploidy. Clin. Cancer Res. 4, 2169-2177
26. Gorlick, R., Goker, E., Trippett, T., Steinherz, P., Elisseyeff, Y., Mazumdar, M., Flintoff, W. F. and Bertino, J. R. (1997) Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphoblastic leukemia and is associated with decreased reduced folate carrier expression. Blood 89, 1013-1018
27. Wang, Y., Zhao, R., Russell, R. G. and Goldman, I. D. (2001) Localization of the murine reduced folate carrier as assessed by immunohistochemical analysis. Biochim. Biophys. Acta 1513, 49-54
28. Zhang, L., Wong, S. C. and Matherly, L. H. (1998) Transcript heterogeneity of the human reduced folate carrier results from the use of multiple promoters and variable splicing of alternative upstream exons. Biochem. J. 332, 773-780
29. Tolner, B., Roy, K. and Sirotnak, F. M. (1998) Structural analysis of the human RFC-1 gene encoding a folate transporter reveals multiple promoters and alternatively spliced transcripts with 5′ end heterogeneity. Gene 211, 331-341
30. Williams, F. M. and Flintoff, W. F. (1998) Structural organization of the human reduced folate carrier gene: Evidence for 5′ heterogeneity in lymphoblast mRNA. Somat. Cell Mol. Genet. 24, 143-156
31. Gong, M., Cowan, K. H., Gudas, J. and Moscow, J. A. (1999) Isolation and characterization of genomic sequences involved in the regulation of the human reduced folate carrier gene (RFC1). Gene 233, 21-31
32. Whetstine, J. R. and Matherly, L. H. (2001) The basal promoters for the human reduced folate carrier gene are regulated by a GC-box and a cAMP-response element/AP-1-like element. J. Biol. Chem. 276, 6350-6358
33. Matherly, L. H., Czajkowski, C. A. and Angeles, S. M. (1991) Identification of a highly glycosylated methotrexate membrane carrier in K562 human erythroleukemia cells up-regulated for tetrahydrofolate colactor and methotrexate transport. Cancer Res. 51, 3420-3426
34. Sirotnak, F. M., Moccio, D. M. and Yang, C.-H. (1984) A novel class of genetic variants of the L1210 cell up-regulated for folate analogue transport inward. Isolation, characterization, and degree of metabolic instability of the system. J. Biol. Chem. 259, 13139-13144
35. Yang, C.-H., Sirotnak, F. M. and Mines, L. S. (1988) Further studies on a novel class of genetic variants of the L1210 cell with increased folate analogue transport inward. Transport properties of a new variant, evidence for increased levels of a specific transport protein, and its partial characterization following affinity labeling. J. Biol. Chem. 263, 9703-9709
36. Jansen, G., Westerhof, G. R., Jarmuszewski, M. J., Kathman, I., Rijksen, G. and Schornagel, J. H. (1990) Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. Selective effect on carrier-mediated transport of physiological concentrations of reduced folates. J. Biol. Chem. 265, 18272-18277
37. Wong, S. C., Proefke, S. A., Bhushan, A. and Matherly, L. H. (1995) Isolation of human cDNAs that restore methotrexate sensitivity and reduced folate carrier activity in methotrexate transport-defective Chinese hamster ovary cells. J. Biol. Chem. 270, 17468-17475
38. Wong, S. C., Zhang, L., Proefke, S. A., Hukku, B. and Matherly, L. H. (1998) Gene amplification and increased expression of the reduced folate carrier in transport elevated K562 cells. Biochem. Pharmacol. 55, 1135-1138
39. Quandt, K., Frech, K., Karas, H., Wingender, E. and Werner, T. (1995) Matind and Matinspector - New fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23, 4878-4884
40. Nguyen, T. T., Dyer, D. L., Dunning, D. D., Rubin, S. A., Grant, K. E. and Said, H. M. (1997) Human intestinal blare transport. Cloning expression and distribution of complementary RNA. Gastroenterology 112, 783-791
41. Chiao, J. H., Roy, K., Tolner, B., Yang, C.-H. and Sirotnak, F. M. (1997) RFC-1 gene expression regulates folate absorption in mouse small intestine. J. Biol. Chem. 272, 11165-11170
42. Prasad, P. D., Ramamoorthy, S., Leibach, F. H. and Ganapathy, V. (1995) Molecular cloning of the human placental folate transporter. Biochem. Biophys. Res. Commun. 206, 681-687
43. Chancy, C. D., Kekuda, R., Huang, W., Prasad, P. D., Kuhnel, J.-M., Sirotnak, F. M., Roon, P., Ganapathy, V. and Smith, S. B. (2000) Expression and differential polarization of the reduced-folate transporter-1 and the folate receptor α in mammalian retinal pigment epithelium. J. Biol. Chem. 275, 20676-20684
44. Morshed, K. M., Ros, D. M. and McMartin, K. E. (1997) Folate transport proteins mediate the bidirectional transport of 5-methyltetrahydrofolate in cultured human proximal tubule cells. J. Nutr. 127, 1137-1147
45. Zhao, R., Russell, R. G., Wang, Y., Liu, L., Gao, F., Kneitz, B., Edelmann, W. and Goldman, I. D. (2001) Rescue of embryonic lethality in reduced folate carrier-deficient mice by maternal folic acid supplementation reveals early neonatal failure of hematopoietic organs. J. Biol. Chem. 276, 10224-10228
46. Perry, M. C. (ed.) (1992) The Chemotherapy Source Book, Williams and Wilkins, Baltimore, MD
47. Dorr, R. T. and Von Hoff, D. D. (eds.) (1994) Cancer Chemotherapy Handbook, 2nd Edn, Appleton and Lange, Norwalk, CT
48. Filley, C. M. and Kleinschmidt-Demasters, B. K. (2001) Toxic leukoencephalopathy. N. Engl. J. Med. 345, 425-432
49. Roberts, S. J., Chung, K.-N., Nachmanoff, K. and Elwood, P. C. (1997) Tissue-specific promoters of the α human folate receptor gene yield transcripts with divergent 5′ leader sequences and different translational efficiencies. Biochem. J. 326, 439-447
50. Elwood, P. C., Nachmanoff, K., Saikawa, Y., Page, S. T., Pacheco, P., Roberts, S. and Chung, K.-N. (1997) The divergent 5′ termini of the α human folate receptor (hFR) mRNAs originate from two tissue-specific promoters and alternative splicing: Characterization of the α hFR gene structure. Biochemistry 36, 1467-1478
51. Chen, L., Qi, H., Korneberg, J., Garrow, T. A., Choi, Y.-J. and Shane, B. (1996) Purification and properties of human cytosolic folylpoly-γ-glutamate synthetase and organization, localization, and differential splicing of its gene. J. Biol. Chem. 211, 13077-13087
52. Roy, K., Mitsugi, K. and Sirotnak, F. M. (1996) Organization and alternate splicing of the murine folylpolyglutamate synthetase gene. J. Biol. Chem. 271, 23820-23827
53. Turner, F. B., Andreassi, II, J. L., Ferguson, J., Titus, S., Tse, A., Taylor, S. M. and Moran, R. G. (1999) Tissue-specific expression of functional isoforms of mouse folylpoly-γ-glutamate synthetase: A basis for targeting folate antimetabolites. Cancer Res. 59, 6074-6079
54. Turner, F. B., Taylor, S. M. and Moran, R. G. (2000) Expression patterns of the multiple transcripts from the folylpolyglutamate synthetase gene in human leukemias and normal differentiated tissues. J. Biol. Chem. 275, 35960-35968
55. Kocarek, T. A., Zangar, R. C. and Novak, R. F. (2000) Post-transcriptional regulation of rat CYP2E1 expression: Role of CYP2E1 mRNA untranslated regions in control of translational efficiency and message stability. Arch. Biochem. Biophys. 376, 180-190
56. Fiaschi, T., Chiarugi, P., Veggi, D., Raugei, G. and Ramponi, G. (2000) The inhibitory effect of the 5′ untranslated region of muscle acylphosphatase mRNA on protein expression is relieved during cell differentiation. FEBS Lett. 473, 42-46
57. Fournier, B., Trunong-Bolduc, Q. C., Zhang, X. and Hooper, D. C. (2001) A mutation in the 5′ untranslated region increases stability of norA mRNA, encoding a multidrug resistance transporter of Staphylococcus aureus. J. Bacteriol. 183, 2367-2371